Lilly appoints Lucas Montarce as executive vice president and chief financial officer
Eli Lilly and Company (NYSE: LLY) has appointed Lucas Montarce as executive vice president and chief financial officer (CFO), effective immediately. Montarce, who joined Lilly in 2001, has held various finance leadership roles within the company, including group vice president, corporate controller, and CFO of Lilly Research Laboratories. He most recently served as Lilly president and general manager for the Spain, Portugal and Greece hub.
Montarce holds a bachelor's degree in business accounting from Catholic University (Argentina) and an MBA from the Center for Macroeconomic Studies of Argentina. CEO David A. Ricks expressed confidence in Montarce's abilities, citing his drive, curiosity, and integrity. Montarce stated his commitment to building on Lilly's strong financial foundation and driving continued success as the company expands its global footprint.
Eli Lilly and Company (NYSE: LLY) ha nominato Lucas Montarce come vicepresidente esecutivo e amministratore finanziario (CFO), con effetto immediato. Montarce, che è entrato in Lilly nel 2001, ha ricoperto vari ruoli di leadership finanziaria all'interno dell'azienda, tra cui vicepresidente di gruppo, controllore aziendale e CFO di Lilly Research Laboratories. Ultimamente ha ricoperto il ruolo di presidente e direttore generale per il hub di Spagna, Portogallo e Grecia.
Montarce ha conseguito una laurea in contabilità aziendale presso l'Università Cattolica (Argentina) e un MBA presso il Centro di Studi Macroeconomici dell'Argentina. Il CEO David A. Ricks ha espresso fiducia nelle capacità di Montarce, sottolineando la sua determinazione, curiosità e integrità. Montarce ha dichiarato il suo impegno a costruire ulteriormente sulla solida base finanziaria di Lilly e a guidare il continuo successo mentre l'azienda espande la sua presenza globale.
Eli Lilly and Company (NYSE: LLY) ha nombrado a Lucas Montarce como vicepresidente ejecutivo y director financiero (CFO), con efecto inmediato. Montarce, que se unió a Lilly en 2001, ha ocupado varios roles de liderazgo financiero dentro de la empresa, incluyendo vicepresidente de grupo, controlador corporativo y CFO de Lilly Research Laboratories. Recientemente se desempeñó como presidente y gerente general para el hub de España, Portugal y Grecia.
Montarce tiene una licenciatura en contabilidad de negocios de la Universidad Católica (Argentina) y un MBA del Centro de Estudios Macroeconómicos de Argentina. El CEO David A. Ricks expresó confianza en las habilidades de Montarce, citando su impulso, curiosidad e integridad. Montarce declaró su compromiso de construir sobre la sólida base financiera de Lilly y de impulsar el éxito continuo a medida que la empresa amplía su presencia global.
엘리 릴리 앤 컴퍼니 (NYSE: LLY)는 루카스 몬타르체를 수석 부사장 겸 최고 재무 책임자(CFO)로 즉시 임명했습니다. 몬타르체는 2001년 릴리에 합류한 이후 다양한 재무 리더십 역할을 수행해 왔으며, 그룹 부사장, 기업 감사 및 릴리 연구소의 CFO를 포함합니다. 그는 최근 스페인, 포르투갈 및 그리스 허브의 릴리 사장 및 총괄 관리자 역할을 맡았습니다.
몬타르체는 아르헨티나 가톨릭대학교에서 기업 회계 학사 학위를, 아르헨티나 거시경제 연구소에서 MBA를 취득했습니다. CEO 데이비드 A. 릭스는 몬타르체의 능력에 대한 신뢰를 표시하며 그의 추진력, 호기심 및 진실성을 언급했습니다. 몬타르체는 릴리의 강력한 재무 기반을 바탕으로 지속적인 성공을 추진할 것이라고 다짐했습니다.
Eli Lilly and Company (NYSE: LLY) a nommé Lucas Montarce au poste de vice-président exécutif et directeur financier (CFO), avec effet immédiat. Montarce, qui a rejoint Lilly en 2001, a occupé divers rôles de leadership financier au sein de l'entreprise, notamment vice-président de groupe, contrôleur d'entreprise et CFO de Lilly Research Laboratories. Il a récemment été président et directeur général du pôle Espagne, Portugal et Grèce.
Montarce est titulaire d'un diplôme de licence en comptabilité des affaires de l'Université Catholique (Argentine) et d'un MBA du Centre d'Études Macroeconomiques d'Argentine. Le PDG David A. Ricks a exprimé sa confiance dans les capacités de Montarce, citant sa motivation, sa curiosité et son intégrité. Montarce a affirmé son engagement à s'appuyer sur la solide base financière de Lilly et à conduire un succès continu alors que l'entreprise étend son empreinte mondiale.
Eli Lilly and Company (NYSE: LLY) hat Lucas Montarce zum Executive Vice President und Chief Financial Officer (CFO) ernannt, mit sofortiger Wirkung. Montarce, der 2001 zu Lilly kam, hatte verschiedene Führungspositionen im Finanzbereich inne, darunter Gruppen-Vizepräsident, Unternehmenscontroller und CFO von Lilly Research Laboratories. Zuletzt war er als Präsident und Generaldirektor für den Hub in Spanien, Portugal und Griechenland tätig.
Montarce hat einen Bachelor-Abschluss in Unternehmensbuchhaltung von der Katholischen Universität (Argentinien) sowie einen MBA vom Zentrum für Makroökonomische Studien in Argentinien. CEO David A. Ricks äußerte Vertrauen in Montarces Fähigkeiten und nannte seinen Antrieb, seine Neugier und Integrität. Montarce erklärte sein Engagement, auf der soliden finanziellen Grundlage von Lilly aufzubauen und den anhaltenden Erfolg des Unternehmens bei der Erweiterung seiner globalen Präsenz voranzutreiben.
- Appointment of an experienced internal candidate as CFO
- New CFO has diverse finance leadership experience within the company
- Potential for seamless transition due to Montarce's familiarity with Lilly's operations
- None.
Since joining Lilly in 2001, Montarce has held a range of finance leadership roles, including serving as group vice president, corporate controller and chief financial officer of Lilly Research Laboratories; vice president, finance and chief financial officer of Lilly International; and vice president, finance and global chief financial officer of Elanco Health. He most recently served in the role of Lilly president and general manager for the
"We are excited to announce Lucas as Lilly's next CFO, following a competitive search across health care, tech and general industries," said David A. Ricks, chair and CEO. "Developing leadership talent has always been a strength for Lilly, and Lucas has thrived in a wide variety of roles of increasing scope and impact. Having worked directly with Lucas for more than a decade, I am highly confident he has the drive, curiosity and integrity to excel as our next CFO."
"I am committed to building on our strong financial foundation and helping drive continued success as we expand our global footprint and deliver long-term value to our stakeholders," said Montarce. "I am honored to step into this role during such a significant time in our company's history and look forward to working alongside the executive team and my talented Lilly finance colleagues."
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn. C-LLY
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including about Lilly's leadership and the company's strategic plans, reflecting Lilly's current beliefs and expectations. However, there can be no assurances of achieved objectives or strategy execution as planned. For further discussion of risks and uncertainties relevant to Lilly's business that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
Refer to: | |
Joe Fletcher; jfletcher@lilly.com; (317) 296-2884 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-appoints-lucas-montarce-as-executive-vice-president-and-chief-financial-officer-302241110.html
SOURCE Eli Lilly and Company
FAQ
Who is the new CFO of Eli Lilly (LLY)?
What is Lucas Montarce's background at Eli Lilly (LLY)?
What educational qualifications does Eli Lilly's (LLY) new CFO have?
When did Lucas Montarce's appointment as CFO of Eli Lilly (LLY) take effect?
